These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 18305015)

  • 1. Cotinine selectively activates a subpopulation of alpha3/alpha6beta2 nicotinic receptors in monkey striatum.
    O'Leary K; Parameswaran N; McIntosh JM; Quik M
    J Pharmacol Exp Ther; 2008 May; 325(2):646-54. PubMed ID: 18305015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial recovery of striatal nicotinic receptors in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned monkeys with chronic oral nicotine.
    Bordia T; Parameswaran N; Fan H; Langston JW; McIntosh JM; Quik M
    J Pharmacol Exp Ther; 2006 Oct; 319(1):285-92. PubMed ID: 16837557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease in alpha3*/alpha6* nicotinic receptors but not nicotine-evoked dopamine release in monkey brain after nigrostriatal damage.
    McCallum SE; Parameswaran N; Bordia T; McIntosh JM; Grady SR; Quik M
    Mol Pharmacol; 2005 Sep; 68(3):737-46. PubMed ID: 15933214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment is due to a decline in alpha-conotoxin MII sites.
    Kulak JM; McIntosh JM; Quik M
    Mol Pharmacol; 2002 Jan; 61(1):230-8. PubMed ID: 11752225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes.
    Sharples CG; Kaiser S; Soliakov L; Marks MJ; Collins AC; Washburn M; Wright E; Spencer JA; Gallagher T; Whiteaker P; Wonnacott S
    J Neurosci; 2000 Apr; 20(8):2783-91. PubMed ID: 10751429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varenicline is a potent partial agonist at α6β2* nicotinic acetylcholine receptors in rat and monkey striatum.
    Bordia T; Hrachova M; Chin M; McIntosh JM; Quik M
    J Pharmacol Exp Ther; 2012 Aug; 342(2):327-34. PubMed ID: 22550286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of mesolimbic alpha 3/alpha 6 beta 2 and alpha 4 beta 2 nicotinic acetylcholine receptor sites and function after long-term oral nicotine to monkeys.
    McCallum SE; Parameswaran N; Bordia T; Fan H; McIntosh JM; Quik M
    J Pharmacol Exp Ther; 2006 Jul; 318(1):381-8. PubMed ID: 16622038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α6β2*-subtype nicotinic acetylcholine receptors are more sensitive than α4β2*-subtype receptors to regulation by chronic nicotine administration.
    Marks MJ; Grady SR; Salminen O; Paley MA; Wageman CR; McIntosh JM; Whiteaker P
    J Neurochem; 2014 Jul; 130(2):185-98. PubMed ID: 24661093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys.
    Huang LZ; Parameswaran N; Bordia T; Michael McIntosh J; Quik M
    J Neurochem; 2009 May; 109(3):826-37. PubMed ID: 19250334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement.
    Gotti C; Guiducci S; Tedesco V; Corbioli S; Zanetti L; Moretti M; Zanardi A; Rimondini R; Mugnaini M; Clementi F; Chiamulera C; Zoli M
    J Neurosci; 2010 Apr; 30(15):5311-25. PubMed ID: 20392953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple CNS nicotinic receptors mediate L-dopa-induced dyskinesias: studies with parkinsonian nicotinic receptor knockout mice.
    Quik M; Campos C; Grady SR
    Biochem Pharmacol; 2013 Oct; 86(8):1153-62. PubMed ID: 23831952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nigrostriatal damage preferentially decreases a subpopulation of alpha6beta2* nAChRs in mouse, monkey, and Parkinson's disease striatum.
    Bordia T; Grady SR; McIntosh JM; Quik M
    Mol Pharmacol; 2007 Jul; 72(1):52-61. PubMed ID: 17409284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential roles of α6β2* and α4β2* neuronal nicotinic receptors in nicotine- and cocaine-conditioned reward in mice.
    Sanjakdar SS; Maldoon PP; Marks MJ; Brunzell DH; Maskos U; McIntosh JM; Bowers MS; Damaj MI
    Neuropsychopharmacology; 2015 Jan; 40(2):350-60. PubMed ID: 25035086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of AN6001, a positive allosteric modulator of α6β2-containing nicotinic acetylcholine receptors.
    van Hout M; Klein J; Ahring PK; Brown DT; Thaneshwaran S; Dos Santos AB; Jensen AA; Kohlmeier KA; Christophersen P; Dyhring T
    Biochem Pharmacol; 2020 Apr; 174():113788. PubMed ID: 31887290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term nicotine treatment differentially regulates striatal alpha6alpha4beta2* and alpha6(nonalpha4)beta2* nAChR expression and function.
    Perez XA; Bordia T; McIntosh JM; Grady SR; Quik M
    Mol Pharmacol; 2008 Sep; 74(3):844-53. PubMed ID: 18583454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraquat exposure reduces nicotinic receptor-evoked dopamine release in monkey striatum.
    O'Leary KT; Parameswaran N; Johnston LC; McIntosh JM; Di Monte DA; Quik M
    J Pharmacol Exp Ther; 2008 Oct; 327(1):124-9. PubMed ID: 18606871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Declines in different beta2* nicotinic receptor populations in monkey striatum after nigrostriatal damage.
    Kulak JM; Musachio JL; McIntosh JM; Quik M
    J Pharmacol Exp Ther; 2002 Nov; 303(2):633-9. PubMed ID: 12388645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subunit composition of nicotinic receptors in monkey striatum: effect of treatments with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine or L-DOPA.
    Quik M; Vailati S; Bordia T; Kulak JM; Fan H; McIntosh JM; Clementi F; Gotti C
    Mol Pharmacol; 2005 Jan; 67(1):32-41. PubMed ID: 15470079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in mice.
    Quik M; Sum JD; Whiteaker P; McCallum SE; Marks MJ; Musachio J; McIntosh JM; Collins AC; Grady SR
    Mol Pharmacol; 2003 May; 63(5):1169-79. PubMed ID: 12695545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Iodo-A-85380 binds to alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors (nAChRs) as well as alpha4beta2* subtypes.
    Kulak JM; Sum J; Musachio JL; McIntosh JM; Quik M
    J Neurochem; 2002 Apr; 81(2):403-6. PubMed ID: 12064487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.